Cosmetic products
GLP-compliant safety assessment and alternative test methods for cosmetic products
The safety assessment of cosmetic products requires a systematic, traceable, and scientifically sound evaluation of the potential risks of ingredients and finished products to human health. In this context, cytotoxicity, skin and eye irritation/corrosion, skin sensitization, and genotoxicity/mutagenicity are the fundamental toxicological endpoints. Against the backdrop of the regulatory framework in which animal testing for cosmetic purposes is prohibited, the assessment of these endpoints focuses on alternative methods such as in silico, in chemico, in vitro, and ex vivo, as well as integrated testing approaches.
The safety assessment of cosmetic products is based on a holistic evaluation of exposure scenarios, physico-chemical properties, structure-activity relationships, available toxicological data, and the results of alternative test methods. The ban on animal testing and the marketing of products based on animal test data under the EU Cosmetics Regulation 1223/2009 has accelerated the development and regulatory acceptance of alternative methods. The SCCS guidelines recommend the use of alternative methods within the framework of integrated testing and assessment approaches.
1. Cytotoxicity: Effects on cell viability
Cytotoxicity describes the effects of a substance on cell viability, proliferation, metabolic activity, and membrane integrity. In the safety assessment of cosmetics, cytotoxicity is generally less of an independent risk parameter than an indicator and a tool for dose selection in irritation, eye irritation, and sensitization tests.
2. Skin and eye irritation/corrosion: Irritation potential
Skin and eye irritation or corrosion refers to the potential of a substance to cause reversible or irreversible tissue damage in the contact area. Corrosion is classified as severe tissue damage, whereas irritation is evaluated as reversible inflammation and damage.
3. Skin sensitization (allergy potential): Risk of an allergic reaction
Skin sensitization is the process by which a low-molecular-weight substance binds to proteins in the skin, thereby triggering a specific T-cell response in the immune system and causing allergic contact dermatitis upon subsequent exposures. Toxicologically, this is evaluated based on the key events of the Adverse Outcome Pathway (AOP).
4. Genotoxicity/mutagenicity: Potential to damage genetic material
Genotoxity encompasses DNA damage, chromosome breaks, mutations, or impairment of DNA repair mechanisms. Mutagenicity, on the other hand, is the potential to cause permanent genetic alterations. Screening for genotoxicity in cosmetic ingredients is an important component of the carcinogenicity risk assessment.
GLP and the integration of alternative methods
A GLP-compliant safety assessment must include the following elements:
- Characterization, stability, and solubility of the test substance.
- Validation status of the test system and compliance with the OECD test guideline.
- Quality assurance measures, SOPs, raw data, and archiving.
- Dose-response relationship, controls, and statistical analysis.
- Integrated assessment of in silico, in chemico, in vitro and exposure data.
- Clear reporting on uncertainties and data gaps.
A GLP-compliant safety assessment of cosmetic products requires the evaluation of the endpoints cytotoxicity, skin/eye irritation and corrosion, skin sensitization, and genotoxicity/mutagenicity using alternative methods and integrated approaches. Reconstituted tissue models, cell-based assays, in chemico approaches, and in silico models strengthen the scientific basis of the human health risk assessment while helping to reduce the need for animal testing. For a reliable assessment, GLP infrastructure, method validation, exposure analysis, and the weight-of-evidence approach must be applied together.
For all details and your inquiries, please feel free to contact us.

